The DOI matches its Crossref record; 124 of the 124 references it cites were found in a registry or an index.
NKG2D and Its Ligands: “One for All, All for One”
Open accessAbstract
The activating receptor NKG2D is peculiar in its capability to bind to numerous and highly diversified MHC class I-like self-molecules. These ligands are poorly expressed on normal cells but can be induced on damaged, transformed or infected cells, with the final NKG2D ligand expression resulting from multiple levels of regulation. Although redundant molecular mechanisms can converge in the regulation of all NKG2D ligands, different stimuli can induce specific cellular responses, leading to the expression of one or few ligands. A large body of evidence demonstrates that NK cell activation can be triggered by different NKG2D ligands, often expressed on the same cell, suggesting a functional redundancy of these molecules. However, since a number of evasion mechanisms can reduce membrane expression of these molecules both on virus-infected and tumor cells, the co-expression of different ligands and/or the presence of allelic forms of the same ligand guarantee NKG2D activation in various stressful conditions and cell contexts. Noteworthy, NKG2D ligands can differ in their ability to down-modulate NKG2D membrane expression in human NK cells supporting the idea that NKG2D transduces different signals upon binding various ligands. Moreover, whether proteolytically shed and exosome-associated soluble NKG2D ligands share with their membrane-bound counterparts the same ability to induce NKG2D-mediated signaling is still a matter of debate. Here, we will review recent studies on the NKG2D/NKG2D ligand biology to summarize and discuss the redundancy and/or diversity in ligand expression, regulation, and receptor specificity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Molecular Mechanisms of Mammalian DNA Repair and the DNA Damage Checkpoints
Sancar, A., Lindsey-Boltz, L. A., Ünsal-Kaçmaz, K., & Linn, S. (2004) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.73.011303.073723 · Cited by 3,317 · cited 1×
“In this context, the sensor kinases ATM and ATR can trigger a signaling cascade in which different downstream checkpoint kinases, such as Chk1 and Chk2, are activated together with the key tumor suppressor p53 (54).”
Activation of NK Cells and T Cells by NKG2D, a Receptor for Stress-Inducible MICA
Bauer, S., Groh, V., Wu, J., Steinle, A., Phillips, J. H., Lanier, L. L., & Spies, T. (1999) · Science · doi:10.1126/science.285.5428.727 · Cited by 2,999
Tumour-derived soluble MIC ligands impair expression of NKG2D and T-cell activation
Groh, V., Wu, J., Yee, C., & Spies, T. (2002) · Nature · doi:10.1038/nature01112 · Cited by 1,592
The evolution of gene regulation by transcription factors and microRNAs
Chen, K., & Rajewsky, N. (2007) · Nature Reviews Genetics · doi:10.1038/nrg1990 · Cited by 1,547
The DNA damage pathway regulates innate immune system ligands of the NKG2D receptor
Gasser, S., Orsulic, S., Brown, E. J., & Raulet, D. H. (2005) · Nature · doi:10.1038/nature03884 · Cited by 1,308
An Activating Immunoreceptor Complex Formed by NKG2D and DAP10
Wu, J., Song, Y., Bakker, A. B. H., Bauer, S., Spies, T., Lanier, L. L., & Phillips, J. H. (1999) · Science · doi:10.1126/science.285.5428.730 · Cited by 1,039
Costimulation of CD8αβ T cells by NKG2D via engagement by MIC induced on virus-infected cells
Groh, V., Rhinehart, R., Randolph-Habecker, J., Topp, M. S., Riddell, S. R., & Spies, T. (2001) · Nature Immunology · doi:10.1038/85321 · Cited by 951
Meresse, B., Chen, Z., Ciszewski, C., Tretiakova, M., Bhagat, G., Krausz, T. N., Raulet, D. H., Lanier, L. L., Groh, V., Spies, T., et al. (2004) · Immunity · doi:10.1016/j.immuni.2004.06.020 · Cited by 855
NKG2D-deficient mice are defective in tumor surveillance in models of spontaneous malignancy
Guerra, N., Tan, Y. X., Joncker, N. T., Choy, A., Gallardo, F., Xiong, N., Knoblaugh, S., Cado, D., Greenberg, N. R., & Raulet, D. H. (2008) · Immunity · doi:10.1016/j.immuni.2008.02.016 · Cited by 850
Regulation of Ligands for the NKG2D Activating Receptor
Raulet, D. H., Gasser, S., Gowen, B. G., Deng, W., & Jung, H. (2013) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032712-095951 · Cited by 848
NKG2D Receptor and Its Ligands in Host Defense
Lanier, L. L. (2015) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-15-0098 · Cited by 599 · cited 2×
“Its ligands belong to the H60 (a–c), RAE (α–ε), and MULT1 families in mice, and to the MIC (MICA and MICB) and ULBP (ULBP1–ULBP6) families in humans, where their repertoire is more complex than in other species (1, 2).”
Human Tumor-Derived Exosomes Down-Modulate NKG2D Expression
Clayton, A., Mitchell, J. P., Court, J., Linnane, S., Mason, M. D., & Tabi, Z. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.11.7249 · Cited by 574
Effect of NKG2D ligand expression on host immune responses
Champsaur, M., & Lanier, L. L. (2010) · Immunological Reviews · doi:10.1111/j.0105-2896.2010.00893.x · Cited by 488
New class of microRNA targets containing simultaneous 5′-UTR and 3′-UTR interaction sites
Lee, I., Ajay, S. S., Yook, J. I., Kim, H. S., Hong, S. H., Kim, N. H., Dhanasekaran, S. M., Chinnaiyan, A. M., & Athey, B. D. (2009) · Genome Research · doi:10.1101/gr.089367.108 · Cited by 476
Nachmani, D., Stern-Ginossar, N., Sarid, R., & Mandelboim, O. (2009) · Cell Host & Microbe · doi:10.1016/j.chom.2009.03.003 · Cited by 470
Soriani, A., Zingoni, A., Cerboni, C., Iannitto, M. L., Ricciardi, M. R., Di Gialleonardo, V., Cippitelli, M., Fionda, C., Petrucci, M. T., Guarini, A., et al. (2009) · Blood · doi:10.1182/blood-2008-08-173914 · Cited by 460
Self-citationSteinle, A., Li, P., Morris, D. L., Groh, V., Lanier, L. L., Strong, R. K., & Spies, T. (2001) · Immunogenetics · doi:10.1007/s002510100325 · Cited by 454
Ashiru, O., Boutet, P., Fernández-Messina, L., Agüera-González, S., Skepper, J. N., Valés-Gómez, M., & Reyburn, H. T. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-1688 · Cited by 421
MICA Engagement by Human Vγ2Vδ2 T Cells Enhances Their Antigen-Dependent Effector Function
Das, H., Groh, V., Kuijl, C., Sugita, M., Morita, C. T., Spies, T., & Bukowski, J. F. (2001) · Immunity · doi:10.1016/s1074-7613(01)00168-6 · Cited by 409
Tumor-Associated MICA Is Shed by ADAM Proteases
Waldhauer, I., Goehlsdorf, D., Gieseke, F., Weinschenk, T., Wittenbrink, M., Ludwig, A., Stevanovic, S., Rammensee, H.-G., & Steinle, A. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-6768 · Cited by 375
Promiscuity and the single receptor: NKG2D
Eagle, R. A., & Trowsdale, J. (2007) · Nature Reviews Immunology · doi:10.1038/nri2144 · Cited by 374
NKG2D-DAP10 triggers human NK cell–mediated killing via a Syk-independent regulatory pathway
Billadeau, D. D., Upshaw, J. L., Schoon, R. A., Dick, C. J., & Leibson, P. J. (2003) · Nature Immunology · doi:10.1038/ni929 · Cited by 374
Hedlund, M., Nagaeva, O., Kargl, D., Baranov, V., & Mincheva-Nilsson, L. (2011) · PLoS ONE · doi:10.1371/journal.pone.0016899 · Cited by 360
Evasion from NK Cell Immunity by MHC Class I Chain-Related Molecules Expressing Colon Adenocarcinoma
Doubrovina, E. S., Doubrovin, M. M., Vider, E., Sisson, R. B., O’Reilly, R. J., Dupont, B., & Vyas, Y. M. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.12.6891 · Cited by 324
Human microRNAs regulate stress-induced immune responses mediated by the receptor NKG2D
Stern-Ginossar, N., Gur, C., Biton, M., Horwitz, E., Elboim, M., Stanietsky, N., Mandelboim, M., & Mandelboim, O. (2008) · Nature Immunology · doi:10.1038/ni.1642 · Cited by 315
Activation of Vγ9Vδ2 T Cells by NKG2D
Rincon-Orozco, B., Kunzmann, V., Wrobel, P., Kabelitz, D., Steinle, A., & Herrmann, T. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.4.2144 · Cited by 313
Upshaw, J. L., Arneson, L. N., Schoon, R. A., Dick, C. J., Billadeau, D. D., & Leibson, P. J. (2006) · Nature Immunology · doi:10.1038/ni1325 · Cited by 300
Cerboni, C., Zingoni, A., Cippitelli, M., Piccoli, M., Frati, L., & Santoni, A. (2007) · Blood · doi:10.1182/blood-2006-10-052720 · Cited by 297
Self-citationBryceson, Y. T., Ljunggren, H.-G., & Long, E. O. (2009) · Blood · doi:10.1182/blood-2009-01-201632 · Cited by 286
A shed NKG2D ligand that promotes natural killer cell activation and tumor rejection
Deng, W., Gowen, B. G., Zhang, L., Wang, L., Lau, S., Iannello, A., Xu, J., Rovis, T. L., Xiong, N., & Raulet, D. H. (2015) · Science · doi:10.1126/science.1258867 · Cited by 255
Proteolytic Release of Soluble UL16-Binding Protein 2 from Tumor Cells
Waldhauer, I., & Steinle, A. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-2520 · Cited by 245
Systemic NKG2D Down-Regulation Impairs NK and CD8 T Cell Responses In Vivo
Wiemann, K., Mittrücker, H.-W., Feger, U., Welte, S. A., Yokoyama, W. M., Spies, T., Rammensee, H.-G., & Steinle, A. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.2.720 · Cited by 240
Modulation of natural killer cells by human cytomegalovirus
Wilkinson, G. W. G., Tomasec, P., Stanton, R. J., Armstrong, M., Prod’homme, V., Aicheler, R., McSharry, B. P., Rickards, C. R., Cochrane, D., Llewellyn-Lacey, S., et al. (2008) · Journal of Clinical Virology · doi:10.1016/j.jcv.2007.10.027 · Cited by 239
Hilpert, J., Grosse-Hovest, L., Grünebach, F., Buechele, C., Nuebling, T., Raum, T., Steinle, A., & Salih, H. R. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1200796 · Cited by 238
Textor, S., Fiegler, N., Arnold, A., Porgador, A., Hofmann, T. G., & Cerwenka, A. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-3211 · Cited by 221
Gobbo, J., Marcion, G., Cordonnier, M., Dias, A. M. M., Pernet, N., Hammann, A., Richaud, S., Mjahed, H., Isambert, N., Clausse, V., et al. (2016) · Journal of the National Cancer Institute · doi:10.1093/jnci/djv330 · Cited by 205
Venkataraman, G. M., Suciu, D., Groh, V., Boss, J. M., & Spies, T. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.2.961 · Cited by 191
Barsoum, I. B., Hamilton, T. K., Li, X., Cotechini, T., Miles, E. A., Siemens, D. R., & Graham, C. H. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-2104 · Cited by 188
Chitadze, G., Lettau, M., Bhat, J., Wesch, D., Steinle, A., Fürst, D., Mytilineos, J., Kalthoff, H., Janssen, O., Oberg, H., et al. (2013) · International Journal of Cancer · doi:10.1002/ijc.28174 · Cited by 188
Heinemann, A., Zhao, F., Pechlivanis, S., Eberle, J., Steinle, A., Diederichs, S., Schadendorf, D., & Paschen, A. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-1977 · Cited by 187
Rölle, A., Mousavi-Jazi, M., Eriksson, M., Odeberg, J., Söderberg-Nauclér, C., Cosman, D., Kärre, K., & Cerboni, C. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.2.902 · Cited by 186
Self-citationChitadze, G., Bhat, J., Lettau, M., Janssen, O., & Kabelitz, D. (2013) · Scandinavian Journal of Immunology · doi:10.1111/sji.12072 · Cited by 186
RAE1 Ligands for the NKG2D Receptor Are Regulated by STING-Dependent DNA Sensor Pathways in Lymphoma
Lam, A. R., Le Bert, N., Ho, S. S. W., Shen, Y. J., Tang, M. L. F., Xiong, G. M., Croxford, J. L., Koo, C. X., Ishii, K. J., Akira, S., et al. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-1703 · Cited by 179
Bauman, Y., Nachmani, D., Vitenshtein, A., Tsukerman, P., Drayman, N., Stern-Ginossar, N., Lankry, D., Gruda, R., & Mandelboim, O. (2011) · Cell Host & Microbe · doi:10.1016/j.chom.2011.01.008 · Cited by 178
Thomas, M., Boname, J. M., Field, S., Nejentsev, S., Salio, M., Cerundolo, V., Wills, M., & Lehner, P. J. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0707883105 · Cited by 176
Function of NKG2D in natural killer cell–mediated rejection of mouse bone marrow grafts
Ogasawara, K., Benjamin, J., Takaki, R., Phillips, J. H., & Lanier, L. L. (2005) · Nature Immunology · doi:10.1038/ni1236 · Cited by 169
NKG2D signaling is coupled to the interleukin 15 receptor signaling pathway
Horng, T., Bezbradica, J. S., & Medzhitov, R. (2007) · Nature Immunology · doi:10.1038/ni1524 · Cited by 168
Differential Mechanisms of Shedding of the Glycosylphosphatidylinositol (GPI)-anchored NKG2D Ligands
Fernández‐Messina, L., Ashiru, O., Boutet, P., Agüera‐González, S., Skepper, J. N., Reyburn, H. T., & Valés‐Gómez, M. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.045906 · Cited by 167
Nachmani, D., Lankry, D., Wolf, D. G., & Mandelboim, O. (2010) · Nature Immunology · doi:10.1038/ni.1916 · Cited by 158
NKG2D Ligands in Tumor Immunity: Two Sides of a Coin
Zhang, J., Basher, F., & Wu, J. D. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00097 · Cited by 156
Cerboni, C., Fionda, C., Soriani, A., Zingoni, A., Doria, M., Cippitelli, M., & Santoni, A. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00508 · Cited by 150
Self-citationBoutet, P., Agüera‐González, S., Atkinson, S. J., Pennington, C. J., Edwards, D. R., Murphy, G., Reyburn, H. T., & Valés‐Gómez, M. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.182.1.49 · Cited by 146
Hypoxia Increases Tumor Cell Shedding of MHC Class I Chain-Related Molecule: Role of Nitric Oxide
Siemens, D. R., Hu, N., Sheikhi, A., Chung, E., Frederiksen, L. J., Pross, H. F., & Graham, C. H. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-0054 · Cited by 145
The DNA damage response, immunity and cancer
Gasser, S., & Raulet, D. H. (2006) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2006.07.004 · Cited by 136
ULBP6/RAET1L is an additional human NKG2D ligand
Eagle, R. A., Traherne, J. A., Hair, J. R., Jafferji, I., & Trowsdale, J. (2009) · European Journal of Immunology · doi:10.1002/eji.200939502 · Cited by 132
Liu, G., Atteridge, C. L., Wang, X., Lundgren, A. D., & Wu, J. D. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0903789 · Cited by 131
López‐Soto, A., Folgueras, A. R., Seto, E., & Gonzalez, S. R. (2009) · Oncogene · doi:10.1038/onc.2009.117 · Cited by 130
Breunig, C., Pahl, J. H. W., Kueblbeck, M., Miller, M., Antonelli, D., Erdem, N., Wirth, C., Will, R. D., Bott, A., Cerwenka, A., et al. (2017) · Cell Death and Disease · doi:10.1038/cddis.2017.364 · Cited by 130
Kim, H. S., Das, A., Groß, C. C., Bryceson, Y. T., & Long, E. O. (2010) · Immunity · doi:10.1016/j.immuni.2010.02.004 · Cited by 129
Markiewicz, M. A., Carayannopoulos, L. N., Naidenko, O. V., Matsui, K., Burack, R., Wise, E. L., Fremont, D. H., Allen, P. M., Yokoyama, W. M., Colonna, M., et al. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.5.2825 · Cited by 126
Vulpis, E., Cecere, F., Molfetta, R., Soriani, A., Fionda, C., Peruzzi, G., Caracciolo, G., Palchetti, S., Masuelli, L., Simonelli, L., et al. (2017) · OncoImmunology · doi:10.1080/2162402x.2017.1279372 · Cited by 126
Self-citationLi, H., Lakshmikanth, T., Garofalo, C., Enge, M., Spinnler, C., Anichini, A., Székely, L., Kärre, K., Carbone, E., & Selivanova, G. (2011) · Cell Cycle · doi:10.4161/cc.10.19.17630 · Cited by 125
Xie, J., Liu, M., Li, Y., Nie, Y., Mi, Q., & Zhao, S. (2014) · Cellular and Molecular Immunology · doi:10.1038/cmi.2014.30 · Cited by 124
Kato, N., Tanaka, J., Sugita, J., Toubai, T., Miura, Y., Ibata, M., Syono, Y., Ota, S., Kondo, T., Asaka, M., et al. (2007) · Leukemia · doi:10.1038/sj.leu.2404862 · Cited by 123
Jung, H., Hsiung, B., Pestal, K., Procyk, E., & Raulet, D. H. (2012) · Journal of Experimental Medicine · doi:10.1084/jem.20120565 · Cited by 123
NF-κB Regulates Expression of the MHC Class I-Related Chain A Gene in Activated T Lymphocytes
Molinero, L. L., Fuertes, M. B., Girart, M. V., Fainboim, L., Rabinovich, G. A., Costas, M. A., & Zwirner, N. W. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.9.5583 · Cited by 116
Ehrlich, L. I. R., Ogasawara, K., Hamerman, J., Takaki, R., Zingoni, A., Allison, J., & Lanier, L. (2005) · Journal of Immunology · doi:10.4049/jimmunol.174.4.1922 · Cited by 113
Self-citationPosttranslational regulation of the NKG2D ligand Mult1 in response to cell stress
Nice, T. J., Coscoy, L., & Raulet, D. H. (2009) · The Journal of Experimental Medicine · doi:10.1084/jem.20081335 · Cited by 113
Fuertes, M. B., Girart, M. V., Molinero, L. L., Domaica, C. I., Rossi, L. E., Barrio, M. M., Mordoh, J., Rabinovich, G. A., & Zwirner, N. W. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.7.4606 · Cited by 112
Yadav, D., Ngolab, J., Lim, R. S.-H., Krishnamurthy, S. R., & Bui, J. D. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.182.1.39 · Cited by 108
Methylation of NKG2D ligands contributes to immune system evasion in acute myeloid leukemia
Raneros, A. B., Martín‐Palanco, V., Fernández, A. F., Rodríguez, R. M. A., Fraga, M. F., López‐Larrea, C., & Suárez-Álvarez, B. (2014) · Genes and Immunity · doi:10.1038/gene.2014.58 · Cited by 106
Regulation of NKG2D Ligand Gene Expression
Eagle, R. A., Traherne, J. A., Ashiru, O., Wills, M. R., & Trowsdale, J. (2006) · Human Immunology · doi:10.1016/j.humimm.2006.02.015 · Cited by 105
Soriani, A., Iannitto, M. L., Ricci, B., Fionda, C., Malgarini, G., Morrone, S., Peruzzi, G., Ricciardi, M. R., Petrucci, M. T., Cippitelli, M., et al. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1400271 · Cited by 104
Self-citationZingoni, A., Cecere, F., Vulpis, E., Fionda, C., Molfetta, R., Soriani, A., Petrucci, M. T., Ricciardi, M. R., Fuerst, D., Amendola, M. G., et al. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1402643 · Cited by 103
Self-citationAbruzzese, M. P., Bilotta, M. T., Fionda, C., Zingoni, A., Soriani, A., Vulpis, E., Borrelli, C., Zitti, B., Petrucci, M. T., Ricciardi, M. R., et al. (2016) · Journal of Hematology & Oncology · doi:10.1186/s13045-016-0362-2 · Cited by 102
Self-citationBedel, R., Thiery-Vuillemin, A., Grandclément, C., Balland, J., Rémy-Martin, J., Kantelip, B., Pallandre, J.-R., Pivot, X., Ferrand, C., Tiberghien, P., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-09-4540 · Cited by 99
Shen, J., Pan, J., Du, C., Si, W., Yao, M., Xu, L., Zheng, H., Xu, M., Chen, D., Wang, S., et al. (2017) · Cell Death and Disease · doi:10.1038/cddis.2017.158 · Cited by 97
MicroRNA-mediated down-regulation of NKG2D ligands contributes to glioma immune escape
Codó, P., Weller, M., Meister, G., Szabó, E., Steinle, A., Wolter, M., Reifenberger, G., & Roth, P. (2014) · Oncotarget · doi:10.18632/oncotarget.2287 · Cited by 95
Fionda, C., Abruzzese, M. P., Zingoni, A., Cecere, F., Vulpis, E., Peruzzi, G., Soriani, A., Molfetta, R., Paolini, R., Ricciardi, M. R., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.4603 · Cited by 94
Self-citationFionda, C., Soriani, A., Malgarini, G., Iannitto, M. L., Santoni, A., & Cippitelli, M. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0901797 · Cited by 93
Self-citationLabani‐Motlagh, A., Israelsson, P., Ottander, U., Lundin, E., Nagaev, I., Nagaeva, O., Dehlin, E., Baranov, V. I., & Mincheva‐Nilsson, L. (2015) · Tumor Biology · doi:10.1007/s13277-015-4313-2 · Cited by 93
Beyond Stressed Self: Evidence for NKG2D Ligand Expression on Healthy Cells
Eagle, R. A., Jafferji, I., & Barrow, A. D. (2009) · Current Immunology Reviews · doi:10.2174/157339509787314369 · Cited by 92
Isernhagen, A., Malzahn, D., Viktorova, E. V., Elsner, L., Monecke, S., von Bonin, F., Kilisch, M., Wermuth, J. M., Walther, N., Balavarca, Y., et al. (2015) · EMBO Molecular Medicine · doi:10.15252/emmm.201505246 · Cited by 91
Matusali, G., Tchidjou, H. K., Pontrelli, G., Bernardi, S., d’Ettorre, G., Vullo, V., Buonomini, A. R., Andreoni, M., Santoni, A., Cerboni, C., et al. (2013) · The FASEB Journal · doi:10.1096/fj.12-223057 · Cited by 90
Self-citationWu, X., Yi, T., Hou, J., Meng, X., & Shi, J. (2012) · Neoplasia · doi:10.1593/neo.121236 · Cited by 85
Rossini, G., Cerboni, C., Santoni, A., Landini, M. P., Landolfo, S., Gatti, D., Gribaudo, G., & Varani, S. (2012) · Mediators of Inflammation · doi:10.1155/2012/607276 · Cited by 83
Self-citationSers, C., Kuner, R., Falk, C. S., Lund, P., Sueltmann, H., Braun, M., Buneß, A., Ruschhaupt, M., Conrad, J., Mang‐Fatehi, S., et al. (2009) · International Journal of Cancer · doi:10.1002/ijc.24557 · Cited by 81
Fionda, C., Malgarini, G., Soriani, A., Zingoni, A., Cecere, F., Iannitto, M. L., Ricciardi, M. R., Federico, V., Petrucci, M. T., Santoni, A., et al. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1201426 · Cited by 78
Self-citationProteasome Regulation of ULBP1 Transcription
Butler, J. E., Moore, M. B., Presnell, S. R., Chan, H.-W., Chalupny, N. J., & Lutz, C. T. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0801214 · Cited by 75
Quatrini, L., Molfetta, R., Zitti, B., Peruzzi, G., Fionda, C., Capuano, C., Galandrini, R., Cippitelli, M., Santoni, A., & Paolini, R. (2015) · Science Signaling · doi:10.1126/scisignal.aab2724 · Cited by 72
Self-citationCerboni, C., Ardolino, M., Santoni, A., & Zingoni, A. (2009) · Blood · doi:10.1182/blood-2008-06-165944 · Cited by 70
Self-citationVantourout, P., Willcox, C. R., Turner, A., Swanson, C. M., Haque, Y., Sobolev, O., Grigoriadis, A. E., Tutt, A. N. J., & Hayday, A. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3007579 · Cited by 68
Natural killer cell recognition of in vivo drug-induced senescent multiple myeloma cells
Antonangeli, F., Soriani, A., Ricci, B., Ponzetta, A., Benigni, G., Morrone, S., Bernardini, G., & Santoni, A. (2016) · OncoImmunology · doi:10.1080/2162402x.2016.1218105 · Cited by 68
Self-citationRodríguez‐Rodero, S., Gonzalez, S. R., Rodrigo, L., Fernández-Morera, J. L., Martínez-Borra, J., López‐Vázquez, A., & López‐Larrea, C. (2007) · European Journal of Immunology · doi:10.1002/eji.200737031 · Cited by 67
Hosomi, S., Grootjans, J., Tschurtschenthaler, M., Krupka, N., Matute, J. D., Flak, M. B., Martínez-Naves, E., del Moral, M. G., Glickman, J. N., Ohira, M., et al. (2017) · The Journal of Experimental Medicine · doi:10.1084/jem.20162041 · Cited by 67
Regulation of NKG2D Expression and Signaling by Endocytosis
Molfetta, R., Quatrini, L., Zitti, B., Capuano, C., Galandrini, R., Santoni, A., & Paolini, R. (2016) · Trends in Immunology · doi:10.1016/j.it.2016.08.015 · Cited by 64
Self-citationSchmiedel, D., Tai, J., Yamin, R., Berhani, O., Bauman, Y., & Mandelboim, O. (2016) · eLife · doi:10.7554/elife.13426 · Cited by 62
Gowen, B. G., Chim, B., Marceau, C. D., Greene, T. T., Burr, P., Gonzalez, J. R., Hesser, C. R., Dietzen, P. A., Russell, T. A., Iannello, A., et al. (2015) · eLife · doi:10.7554/elife.08474 · Cited by 58
Isernhagen, A., Schilling, D., Monecke, S., Shah, P. N., Elsner, L., Walter, L., Multhoff, G., & Dressel, R. (2015) · Immunogenetics · doi:10.1007/s00251-015-0884-8 · Cited by 57
c‐Cbl regulates MICA‐ but not ULBP2‐induced NKG2D down‐modulation in human NK cells
Molfetta, R., Quatrini, L., Capuano, C., Gasparrini, F., Zitti, B., Zingoni, A., Galandrini, R., Santoni, A., & Paolini, R. (2014) · European Journal of Immunology · doi:10.1002/eji.201444512 · Cited by 53
Self-citationCellular Expression, Trafficking, and Function of Two Isoforms of Human ULBP5/RAET1G
Eagle, R. A., Flack, G., Warford, A., Martínez-Borra, J., Jafferji, I., Traherne, J. A., Ohashi, M., Boyle, L. H., Barrow, A. D., Caillat‐Zucman, S., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0004503 · Cited by 53
The Traffic of the NKG2D/Dap10 Receptor Complex during Natural Killer (NK) Cell Activation
Roda‐Navarro, P., & Reyburn, H. T. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m808561200 · Cited by 52
Esteso, G., Luzón, E., Sarmiento, E., Gómez-Caro, R., Steinle, A., Murphy, G., Carbone, J., Valés‐Gómez, M., & Reyburn, H. T. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1303441 · Cited by 51
Regulation of Fc Receptor Endocytic Trafficking by Ubiquitination
Molfetta, R., Quatrini, L., Gasparrini, F., Zitti, B., Santoni, A., & Paolini, R. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00449 · Cited by 44
Self-citationMHC class I chain-related gene B (MICB) is associated with rheumatoid arthritis susceptibility
López-Arbesú, R., Ballina‐García, F. J., Alpéri, M., López‐Soto, A., Rodríguez‐Rodero, S., Martı́nez-Borra, J., López‐Vázquez, A., Fernández-Morera, J. L., Riestra-Noriega, J. L., Queiró, R., et al. (2006) · Lara D. Veeken · doi:10.1093/rheumatology/kel331 · Cited by 43
Markiewicz, M. A., Wise, E. L., Buchwald, Z. S., Pinto, A. K., Zafirova, B., Polić, B., & Shaw, A. S. (2012) · Immunity · doi:10.1016/j.immuni.2011.11.014 · Cited by 42
Zuo, J., Willcox, C. R., Mohammed, F., Davey, M. S., Hunter, S., Khan, K., Antoun, A., Katakia, P., Croudace, J. E., Inman, C. F., et al. (2017) · Science Signaling · doi:10.1126/scisignal.aai8904 · Cited by 41
Agüera‐González, S., Boutet, P., Reyburn, H. T., & Valés‐Gómez, M. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0800713 · Cited by 39
RNA-binding proteins regulate the expression of the immune activating ligand MICB
Nachmani, D., Gutschner, T., Reches, A., Diederichs, S., & Mandelboim, O. (2014) · Nature Communications · doi:10.1038/ncomms5186 · Cited by 35
How Mucosal Epithelia Deal with Stress: Role of NKG2D/NKG2D Ligands during Inflammation
Antonangeli, F., Soriani, A., Cerboni, C., Sciumè, G., & Santoni, A. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01583 · Cited by 35
Self-citationPignoloni, B., Fionda, C., Dell’Oste, V., Luganini, A., Cippitelli, M., Zingoni, A., Landolfo, S., Gribaudo, G., Santoni, A., & Cerboni, C. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1502527 · Cited by 34
Self-citationSoriani, A., Borrelli, C., Ricci, B., Molfetta, R., Zingoni, A., Fionda, C., Carnevale, S., Abruzzese, M. P., Petrucci, M. T., Ricciardi, M. R., et al. (2016) · OncoImmunology · doi:10.1080/2162402x.2016.1264564 · Cited by 34
Self-citationDisarming Cellular Alarm Systems—Manipulation of Stress-Induced NKG2D Ligands by Human Herpesviruses
Schmiedel, D., & Mandelboim, O. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00390 · Cited by 34
Antoun, A., Jobson, S., Cook, M. A., O’Callaghan, C. A., Moss, P. A. H., & Briggs, D. (2010) · Human Immunology · doi:10.1016/j.humimm.2010.02.018 · Cited by 33
Heo, W., Lee, Y. S., SON, C. H., Yang, K., Park, Y. S., & BAE, J. (2014) · Molecular Medicine Reports · doi:10.3892/mmr.2014.2918 · Cited by 30
Jensen, H., Andresen, L. O., Nielsen, J., Christensen, J. P., & Skov, S. (2011) · PLoS ONE · doi:10.1371/journal.pone.0023023 · Cited by 29
Mukherjee, S., Jensen, H., Stewart, W., Stewart, D. E., Ray, W. C., Chen, S.-Y., Nolan, G. P., Lanier, L. L., & Das, J. (2017) · Science Signaling · doi:10.1126/scisignal.aai9062 · Cited by 29
Four novel ULBP splice variants are ligands for human NKG2D
Cao, W., Xi, X., Wang, Z., Dong, L., Hao, Z., Cui, L., Ma, C., & He, W. (2008) · International Immunology · doi:10.1093/intimm/dxn057 · Cited by 28
Targeting NKG2D and NKp30 Ligands Shedding to Improve NK Cell-Based Immunotherapy
Zingoni, A., Vulpis, E., Nardone, I., Soriani, A., Fionda, C., Cippitelli, M., & Santoni, A. (2016) · Critical Reviews in Immunology · doi:10.1615/critrevimmunol.2017020166 · Cited by 27
Self-citation5′-UTR and 3′-UTR Regulation of MICB Expression in Human Cancer Cells by Novel microRNAs
Wongfieng, W., Jumnainsong, A., Chamgramol, Y., Sripa, B., & Leelayuwat, C. (2017) · Genes · doi:10.3390/genes8090213 · Cited by 26
Himmelreich, H., Mathys-Schneeberger, A., Wodnar‐Filipowicz, A., & Kalberer, C. P. (2011) · Human Immunology · doi:10.1016/j.humimm.2011.03.005 · Cited by 24
A short half‐life of ULBP1 at the cell surface due to internalization and proteosomal degradation
Fernández‐Messina, L., Reyburn, H. T., & Valés‐Gómez, M. (2016) · Immunology and Cell Biology · doi:10.1038/icb.2016.2 · Cited by 22
Diversity and characterization of polymorphic 5′ promoter haplotypes of MICA and MICB genes
Cox, S. T., Madrigal, J. A., & Saudemont, A. (2014) · Tissue Antigens · doi:10.1111/tan.12400 · Cited by 21
Nagai, Y., Tanaka, Y., Kuroishi, T., Sato, R., Endo, Y., & Sugawara, S. (2012) · Immunology · doi:10.1111/j.1365-2567.2012.03565.x · Cited by 19
Cited by
Exploring the NK cell platform for cancer immunotherapy
Myers, J. A., & Miller, J. S. (2021) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-020-0426-7 · Cited by 1,276
Hair follicle immune privilege and its collapse in alopecia areata
Bertolini, M., McElwee, K., Gilhar, A., Bulfone‐Paus, S., & Paus, R. (2020) · Experimental Dermatology · doi:10.1111/exd.14155 · Cited by 318
NKG2D-CAR T cells eliminate senescent cells in aged mice and nonhuman primates
Yang, D., Sun, B., Li, S., Wei, W., Liu, X., Cui, X., Zhang, X., Liu, N., Yan, L., Deng, Y., et al. (2023) · Science Translational Medicine · doi:10.1126/scitranslmed.add1951 · Cited by 217
Targeting senescent cells with NKG2D-CAR T cells
Deng, Y., Kumar, A., Xie, K., Schaaf, K., Scifo, E., Morsy, S., Li, T., Ehninger, A., Bano, D., & Ehninger, D. (2024) · Cell Death Discovery · doi:10.1038/s41420-024-01976-7 · Cited by 75
Zhang, K., Sakamoto, A., Chang, L., Qu, Y., Wang, S., Pu, Y., Tan, Y., Wang, X., Fujita, Y., Ishima, T., et al. (2021) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-019-01092-z · Cited by 63
Metadata
- Authors
- Zingoni, A., Molfetta, R., Fionda, C., Soriani, A., Paolini, R., Cippitelli, M., Cerboni, C., & Santoni, A.
- Venue
- Frontiers in Immunology
- Publisher
- Frontiers Media SA
- Published
- 2018-03-12
- Volume
- 9
- Pages
- 476-476
- ISSN
- 1664-3224 (ISSN-L)
- OpenAlex
- W2793058090
- Cited by
- 254
- References
- 124
- FWCI
- 9.16
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.